Search Results 241-250 of 8302 for Conduction
Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...
... Conduction system disease, Catecholaminergic polymorphic ventricular tachycardia , Familial cardiomyopathy. Show more areas of focus for Mayank Sardana ...
... Conduction system disease. Show more areas of focus for Anca Chiriac, M.D., Ph.D. Pagination Doctor search. Go to page 11 · Go to page 22 · NextNext Page. Learn ...
Subjects with VTs of septal origin require special care to minimize the risk of heart block, particularly within 2 cm of the AV node/proximal conduction ...
Active conduction system abnormalities; NOTE: prior to study entry, any electrocardiogram (ECG) abnormality at screening must be documented by the ...
Evidence of any of the following cardiac conduction abnormalities during the screening period: A QTc Fredericia interval >450 milliseconds for males and ...
For subjects with an intraventricular conduction delay (QRS interval > 120 msec), the JTc interval may be used in place of the QTc with sponsor approval.
Requires treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.